- Home
- DYNX vs STIM Comparison
DYNX vs STIM Comparison
Compare DYNX & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYNX
- STIM
- Stock Information
- Founded
- DYNX 2024
- STIM 2003
- Country
- DYNX United States
- STIM United States
- Employees
- DYNX N/A
- STIM N/A
- Industry
- DYNX
- STIM Medical/Dental Instruments
- Sector
- DYNX
- STIM Health Care
- Exchange
- DYNX NYSE
- STIM Nasdaq
- Market Cap
- DYNX 221.3M
- STIM 232.3M
- IPO Year
- DYNX 2024
- STIM 2018
- Fundamental
- Price
- DYNX $10.06
- STIM $3.81
- Analyst Decision
- DYNX
- STIM Buy
- Analyst Count
- DYNX 0
- STIM 4
- Target Price
- DYNX N/A
- STIM $6.00
- AVG Volume (30 Days)
- DYNX 13.6K
- STIM 885.6K
- Earning Date
- DYNX 01-01-0001
- STIM 05-06-2025
- Dividend Yield
- DYNX N/A
- STIM N/A
- EPS Growth
- DYNX N/A
- STIM N/A
- EPS
- DYNX N/A
- STIM N/A
- Revenue
- DYNX N/A
- STIM $89,448,000.00
- Revenue This Year
- DYNX N/A
- STIM $104.65
- Revenue Next Year
- DYNX N/A
- STIM $10.69
- P/E Ratio
- DYNX N/A
- STIM N/A
- Revenue Growth
- DYNX N/A
- STIM 22.16
- 52 Week Low
- DYNX $9.78
- STIM $0.52
- 52 Week High
- DYNX $10.48
- STIM $5.92
- Technical
- Relative Strength Index (RSI)
- DYNX N/A
- STIM 38.28
- Support Level
- DYNX N/A
- STIM $3.78
- Resistance Level
- DYNX N/A
- STIM $4.00
- Average True Range (ATR)
- DYNX 0.00
- STIM 0.24
- MACD
- DYNX 0.00
- STIM -0.05
- Stochastic Oscillator
- DYNX 0.00
- STIM 6.92
About DYNX DYNAMIX CORP
Dynamix Corp is a blank check company.
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.